HLA-Specific Antibody Screening
(H & I)
Investigation : HLA-Specific Antibody Screening
Investigations HLA-Specific Antibody Screening
Inform lab before sending Not usually required, for renal transplant patients the users are reminded to send samples on a 3-monthly basis. For urgent renal patient samples please contact the Consultant Clinical Scientist in the first instance.
Stem cell transplant patients requiring antibody screening, the H&I laboratory will contact the stem cell transplant department to request a sample for analysis
Specimen type Patient:
  • 10ml clotted blood
  • Ideal time to take specimen Samples are routinely screened for renal patients on a 3 monthly basis with testing taking place in January, April, July, and October.
    Labelling requirements click here
    How to take the specimen no preservative
    Transport to the laboratory  
    Test Times Renal patient samples are required on a three monthly basis to keep an up to date immunological history for each patient.
    Turnround 4 weeks
    Additional information Patients who test positive for HLA antibodies on this initial screening test will be sent for further antibody characterisation testing in accordance with the H&I renal transplant policy. The assay uses panels of HLA antigen coated beads coupled to microspheres and analysed using the Luminex platform.
    Additional Examination Requests A primary sample must be received for this test


    Laboratory Services Home Page